tiprankstipranks
Trending News
More News >
Urogen Pharma (URGN)
NASDAQ:URGN
US Market

Urogen Pharma (URGN) Technical Analysis

Compare
561 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
2Neutral
6Bearish
Technical Analysis Consensus
Sell
2Bullish
2Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Urogen Pharma’s (URGN) Moving Averages Convergence Divergence (MACD) indicator is 0.70, suggesting Urogen Pharma is a Sell.
Urogen Pharma’s (URGN) 20-Day exponential moving average is 8.12, while Urogen Pharma’s (URGN) share price is $14.34, making it a Buy.
Urogen Pharma’s (URGN) 50-Day exponential moving average is 8.53, while Urogen Pharma’s (URGN) share price is $14.34, making it a Buy.

Urogen Pharma (URGN) Pivot Points

Jun 18, 2025, 05:35 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
8.15
9.83
10.93
12.61
13.71
15.39
16.49
Fibonacci
9.83
10.89
11.55
12.61
13.67
14.33
15.39
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Urogen Pharma (URGN) Moving Averages

Jun 18, 2025, 05:35 AM
Period
Simple
Exponential
MA5
10.36Buy
11.09Buy
MA10
8.12Buy
9.18Buy
MA20
6.51Buy
8.12Buy
MA50
8.75Buy
8.53Buy
MA100
9.73Buy
9.49Buy
MA200
10.92Buy
11.06Buy
Urogen Pharma’s (URGN) 10-Day exponential moving average is 9.18, while Urogen Pharma’s (URGN) share price is $14.34, making it a Buy.
Urogen Pharma’s (URGN) 100-Day exponential moving average is 9.49, while Urogen Pharma’s (URGN) share price is $14.34, making it a Buy.
Urogen Pharma’s (URGN) stock price is $14.34 and Urogen Pharma’s (URGN) 50-day simple moving average is 8.75, creating a Buy signal.
Urogen Pharma’s (URGN) stock price is $14.34 and Urogen Pharma’s (URGN) 100-day simple moving average is 9.73, creating a Buy signal.
Urogen Pharma’s (URGN) stock price is $14.34 and Urogen Pharma’s (URGN) 200-day simple moving average is 10.92, creating a Buy signal.

Urogen Pharma (URGN) Technical Indicators

Jun 18, 2025, 05:35 AM
Name
Value
Implied Action
RSI (14)
77.11
Sell
STOCH (9,6)
85.15
Sell
STOCHRSI (14)
86.58
Sell
MACD (12,26)
0.70
Sell
ADX (14)
35.16
Neutral
Williams %R
-3.16
Sell
CCI (14)
217.88
Sell
ATR (14)
1.53
-
Ultimate Oscillator
61.45
Neutral
ROC
264.89
Buy
Urogen Pharma’s (URGN) Relative Strength Index (RSI) is 77.11, creating a Sell signal.
Urogen Pharma’s (URGN) Trend Strength Indicator (ADX) is 35.16, creating a Neutral signal.
Urogen Pharma’s (URGN) Commodity Channel Index (CCI) is 217.88, creating a Sell signal.
Urogen Pharma’s (URGN) Price Rate of Change (ROC) is 264.89, creating a Buy signal.

FAQ

Is URGN a Buy, Hold, or Sell?
Based on URGN’s technical indicators, URGN is a Buy.
    What is URGN’s RSI (14)?
    URGN’s RSI (14) is 77.11, which suggests URGN is a Sell.
      What is URGN’s MACD?
      URGN’s MACD is 0.70, which suggests URGN is a Sell.
        What is URGN’s 5-day moving average?
        URGN’s 5-day moving average is 10.36, which suggests URGN is a Buy.
          What is URGN’s 20-day moving average?
          URGN 20-day moving average is 6.51, which suggests URGN is a Buy.
            What is URGN’s 50-day moving average?
            URGN’s 50-day moving average is 8.75, which suggests URGN is a Buy.
              What is URGN’s 200-day moving average?
              URGN’s 200-day moving average is 10.92, which suggests URGN is a Buy.
                What is URGN’s Williams % R (14)?
                URGN’s Williams % R (14) is -3.16, which suggests URGN is a Sell.
                  What is URGN’s CCI (14)?
                  URGN’s CCI (14) is 217.88, which suggests URGN is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis